Gate Bioscience

California, United States · Biotechnology, Health Care · 42 employees

Gate Bioscience is a preclinical biotechnology company creating a new class of medicines called Molecular Gates. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin: inside the cell. Humans produce over 4,000 distinct extracellular proteins, more than 1,000 of which can drive disease when they act improperly, misfold, or are made a

See plans & pricing → Track Gate Bioscience’s funding, hiring, and signals — with verified contacts — on Fundz.